2024-10-19 00:20:28
Oral semaglutide demonstrated cardiovascular safety in people with type 2 diabetes and established cardiovascular disease or high cardiovascular risk in PIONEER 6 trial
Health/ 2023-07-22
Oral semaglutide demonstrated cardiovasc...

SAN FRANCISCO,June 12,2019-- Novo Nordisk today announced that the PIONEER 6 trial achieved its primary endpoint by demonstrating non-inferi...

CartiHeal Enrolls the 200th Patient in Its Pivotal Clinical Study in San Diego, CA
Health/ 2023-07-22
CartiHeal Enrolls the 200th Patient in I...

KFAR SABA,Israel,June 12,2019-- CartiHeal,developer of the Agili-C™ implant for treating cartilage and osteochondral defects in traumatic a...

CUSMail

CusMail provide the Latest News , Business and Technology News Release service. Most of our news is paid for distribution to meet global marketing needs. We can provide you with global market support.

© CUSMAIL. All Rights Reserved. Operate by Paid Release